Mesothelioma treatment is a rapidly advancing field.  Improvements and promising steps forward are made on a regular basis, as modern science does its best to catch up with this ravaging cancer.  Despite what appears to be a constant, if gradual and experimental, march of progress, however, there unfortunately remains no cure for mesothelioma.

Of the three primary methods of treatment for most cancers—surgery, radiation therapy, and chemotherapy—none has proven particularly effective.  One of the more effective treatments used by surgeons is a procedure known as a pneumonectomy, which involves intense chemotherapy combined with the removal of a lung.  Although this treatment does not typically result in a cure for the patient, it can extend that patient’s life.

Any extension of a mesothelioma victim’s life can be a pretty big deal, especially since the average life expectancy of someone diagnosed with this cancer is less than two years.  From the onset of symptoms, the disease moves very rapidly.

Mesothelioma, thankfully, is a very rare disease.  Only somewhere between seven and 40 in a 1,000,000 get it in the United States of America, which is a blessedly low rate.  However, this low rate of prevalence is yet another reason why it’s so difficult to treat effectively.  That’s because there is very little comparative data on mesothelioma out there.  There are projects that attempt to compile disease data, like the Cornell University Mesothelioma Program, which works to establish a national registry of all mesothelioma cases, but the sheer lack of victims results in a lack of studies, which, in turn, means fewer big steps forward.

No matter what happens, it might be a good idea to consult with a mesothelioma law firm about securing a mesothelioma settlement.  When looking for one, think about the amount of experience that law firm has when dealing with cases of that nature, along with the track record it’s amounted.  Gathering those two bits of information will help you make a more well-informed decision, because a mesothelioma lawsuit or settlement is not something that can easily be taken lightly.

Mesothelioma lawsuits have traditionally been high-stakes, but the outcome of a recent trial in California might be uncharted territory, as far as payout size is concerned.

According to an article found on the Surviving Mesothelioma site, jurors in a recent case involving a woman who allegedly contracted mesothelioma by washing her husband’s asbestos-tainted clothing ruled in her favor, awarding her $208.8 million in total damages.  Of that total, $8.8 million was compensatory, while $200 million was punitive.

The article states that Bobby Evans, a worker for the L.A. Department of Water and Power from 1974 to 1998, had to, among other things, had to cut asbestos cement pipes as part of his job’s duties.  These pipes, manufactured by CertainTeed Corporation, released asbestos fibers into the air when cut.  These fibers then settled into his clothing, which were then apparently released into the air when his wife, Rhoda, washed them.

Unfortunately, there is nothing new about this claim.  Many industries, but primarily the shipbuilding and construction ones, historically used asbestos as an insulator and a fire retardant.  It did both jobs well, and was a remarkably light material to boot, so it was highly prized.  Unfortunately, it also causes devastating lung diseases, including mesothelioma, asbestosis, and other debilitating cancers.  It decimated workers in those very industries that used it most.

What’s more, the lightweight fibers did have a tendency to get stuck in clothing and hair, which could then be disturbed in workers’ households and inhaled by his family.  Hence the very real possibility that this is indeed what happened to Rhoda Evans.

Though $208.8 million seems like a staggering payday, there’s a good chance that the final amount will be lowered in an appeal.  What’s more, mesothelioma is an absolutely ravaging disease, one that, as of now, has no apparent cure.  Despite constant improvements in mesothelioma treatment, the life expectancy of a victim is often measured in months, not years.

There’s more good news for mesothelioma treatment on the horizon.  According to an article posted on the always-helpful Asbestos.com, a promising treatment for this disease might lie in immuno-gene therapy.  This cutting-edge treatment method involves boosting the immune system through a variety of methods.  One involves the introduction of a virus whose genetic material has been altered to include a normal, human gene into the area where the mesothelioma is.  When this virus enters cancer cells, it triggers those cells to begin producing normal proteins, not defective ones.  Another method involves the introduction of coated DNA into the system.

Though immuno-gene therapy is a potentially fertile region for discovery, there are some hang-ups regarding this treatment.  First, there are concerns that the body’s own immune system, despite being comprised, might reject the infectious cells rapidly.  From a legal perspective, since the FDA has yet to approve immuno-gene therapy, the treatment is only available to those patients who qualify for clinical trials.  Still, it could be a step in the right direction.

About Mesothelioma

Mesothelioma is an insidious and startlingly effective killer.  It is caused by asbestos, a fibrous mineral formerly prized in many industries, and particularly in ship-building and construction, for its excellent flame-retardant and insulation properties.  Unfortunately, for all its utility, asbestos fibers, when inhaled, can utterly ravage the lungs.  One way it does this is by fibers getting embedded in the pleural lining of the lungs.  This can happen without noticeable adverse affects for up to 50 years; however, once the mesothelioma’s onset occurs, patients rapidly deteriorate.  For all the forward advancements the medical field offers on a regular basis, the life expectancy of those diagnosed with this devastating, rare disease is often measured in months, not not years.

Nevertheless, we here at the Mesothelioma Help Network eagerly hope that science will one day catch up to this brutal cancer, rendering it a curable disease.  Who knows?  One of these experimental treatments on the horizon just might point the way to such a future.

According to a promising article posted by the fine folks over at AboutMesothelioma.net, an experimental drug used for treating cancer, known as NGR-hTNF, had positive results when used as a means of treating mesothelioma.

According to the study, 57 patients who had already received chemotherapy treatment and had experienced a relapse of the disease were given the drug.  NGR-hTNF combines an amino acid sequence known as a peptide with a protein that helps bolster the immune system’s response to tumor growth.  The drug seemed to be somewhat effective at temporarily stopping the advance of the cancer, which affects the pleural lining of the lung, in 26 of the patients.  The length of the effectiveness appeared to be five months, and the median length of survival for patients was 12 months.

This might seem like bleak and not-particularly-good news, but mesothelioma is such a ravaging and devastating disease that any bit of news like this is emphatically good news.  With a cancer like mesothelioma, where the prognosis is almost always death and where the lifespan of those diagnosed is often measured in months, not years, every step forward is a great leap in the right direction.

Mesothelioma Treatment

If you are diagnosed with this devastating disease, it might be a good idea to contact an experienced mesothelioma lawyer with a proven track record of success.  When picking such a lawyer or law firm, be sure to do your homework.  Taking their win/loss ratio into account is usually a good tactic.  Though previous case histories don’t guarantee a particular outcome, since each case is different, you might be able to look at it as an indicator of the competence of the lawyer in question.

Though a mesothelioma diagnosis is a terrible affliction, there are constantly advances in treatments, many of which can improve the quality of life of victims.  Who knows—one day, if we’re lucky, this disease might be easily curable.  We have hope.